Hostname: page-component-848d4c4894-v5vhk Total loading time: 0 Render date: 2024-07-03T17:50:14.815Z Has data issue: false hasContentIssue false

Antibiotic Stewardship and Clostridium difficile–Associated Disease

Published online by Cambridge University Press:  02 January 2015

Franziska Nuila
Affiliation:
Medical Service (Infectious Disease Section), Michael E. DeBakey VA Medical Center, and the Departments of Medicine and Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas
Richard M. Cadle
Affiliation:
Medical Service (Infectious Disease Section), Michael E. DeBakey VA Medical Center, and the Departments of Medicine and Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas
Nancy Logan
Affiliation:
Medical Service (Infectious Disease Section), Michael E. DeBakey VA Medical Center, and the Departments of Medicine and Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas
Daniel M. Musher*
Affiliation:
Medical Service (Infectious Disease Section), Michael E. DeBakey VA Medical Center, and the Departments of Medicine and Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas
*
Infectious Disease Section, Michael E. DeBakey VA Medical Center, 2002 Holcombe Boulevard, Houston, TX 77030 (daniel.musher@med.va.gov)
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2008

References

1.Musher, DM, Aslam, S. Clostridium difficile disease. In: Scheid, WM, Hammer, SM, Hughes, JM, eds. Emerging Infections 8. Washington, DC: ASM Press; 2008:313335.Google Scholar
2.Blossom, DB, McDonald, LC. The challenges posed by reemerging Clostridium difficile infection. Clin Infect Dis 2007;45:222227.CrossRefGoogle ScholarPubMed
3.Fishman, N. Antimicrobial stewardship. Am J Infect Control 2006;34:S55S63; discussion S64-S73.CrossRefGoogle ScholarPubMed
4.McDonald, LC, Coignard, B, Dubberke, E, Song, X, Horan, T, Kutty, PK. Recommendations for Surveillance of Clostridium difficile-Associated Disease. Infect Control Hosp Epidemiol 2007;28:140145.CrossRefGoogle ScholarPubMed
5.Dellit, TH, Owens, RC, McGowan, JE Jr, et al.Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007;44:159177.CrossRefGoogle Scholar
6.Carling, P, Fung, T, Killion, A, Terrin, N, Barza, M. Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years. Infect Control Hosp Epidemiol 2003;24:699706.CrossRefGoogle Scholar
7.McNulty, C, Logan, M, Donald, IP, et al.Successful control of Clostridium difficile infection in an elderly care unit through use of a restrictive antibiotic policy. J Antimicrob Chemother 1997;40:707711.CrossRefGoogle Scholar
8.Muto, CA, Blank, MK, Marsh, JW, et al.Control of an outbreak of infection with the hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive “bundle” approach. Clin Infect Dis 2007;45:12661273.CrossRefGoogle Scholar
9.Musher, DM, Aslam, S, Logan, N, et al.Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole. Clin Infect Dis 2005;40:15861590.CrossRefGoogle ScholarPubMed
10.Robicsek, A, Beaumont, JL, Paule, SM, et al.Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann Intern Med 2008;148:409418.CrossRefGoogle ScholarPubMed